Skip to Main Content

Paper Details

Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease.
Proc Natl Acad Sci U S A
31
2021
AD, Alzheimer's disease, GP, HDL, HDL.C, HDL.L, XL, XL.HDL, XL.HDL.FC, XL.HDLs, acetyls, cholesterol, extra-large high-density lipoproteins, glycoprotein
Author NameAffiliation
Andrew WongUniversity College London
Richard J B DobsonInstitute of Psychiatry, King's College London
Richard J B DobsonNational Institute for Health Research Biomedical Research at South London and Maudsley NHS Foundation Trust and King's College London
Richard J B DobsonUniversity College London
Richard J B DobsonInstitute of Health Informatics, University College London
Richard J B DobsonNational Institute for Health Research Biomedical Research Centre at University College London Hospitals NHS Foundation Trust
Richard J B DobsonInstitute of Psychiatry, King's College London
Richard J B DobsonNational Institute for Health Research Biomedical Research at South London and Maudsley NHS Foundation Trust and King's College London
Richard J B DobsonUniversity College London
Richard J B DobsonInstitute of Health Informatics, University College London
Richard J B DobsonNational Institute for Health Research Biomedical Research Centre at University College London Hospitals NHS Foundation Trust
  • 1 - 11

Datasets

Release 1.2